|Articles|April 26, 2004

Vigamox gets FDA approval for a supplemental list of susceptible pathogens

Fort Lauderdale-The FDA has approved a supplemental list of susceptiblepathogens to the in vitro labeling of Vigamox ophthalmic solution, AlconLaboratories announced Monday.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME